Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Replicase polyprotein 1ab (2019-nCoV) | BDBM512574![]() (WO2021219089, INSCoV-517A (1A)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 30 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512875![]() (WO2021219089, INSCoV-601Q (1A)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 39 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512777![]() (WO2021219089, INCoV-600K (1)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 50 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512832![]() (WO2021219089, INSCoV-601I (1)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 50 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512694![]() (WO2021219089, INSCoV-614 (1B)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 60 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512687![]() (WO2021219089, INSCoV-601S (1A)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 60 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512841![]() (WO2021219089, INSCoV-601K (1)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 60 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512817![]() (WO2021219089, INSCoV-601G (1)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 60 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512831![]() (WO2021219089, INSCoV-601I) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 62 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512774![]() (WO2021219089, INCoV-600J (1) | WO2021219089, INCoV...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 63 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512587![]() (WO2021219089, INSCoV-517C (3)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 70 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512878![]() (WO2021219089, INSCoV-601Q (1B)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 71 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512776![]() (WO2021219089, INCoV-600K) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 78 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512815![]() (WO2021219089, INSCoV-601G) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 80 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512566![]() (WO2021219089, INSCoV-517 (1)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 80 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512891![]() (WO2021219089, INSCoV-601S) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 90 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512573![]() (WO2021219089, INSCoV-517A) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 90 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512839![]() (WO2021219089, INSCoV-601K) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 100 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512829![]() (WO2021219089, INSCoV-601H) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 100 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512581![]() (WO2021219089, INSCoV-517C) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 110 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512773![]() (WO2021219089, INCoV-600J) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 110 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512834![]() (WO2021219089, INSCoV-601J) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 120 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512854![]() (WO2021219089, INSCoV-601N) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 120 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512879![]() (WO2021219089, INSCoV-601R) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 120 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512865![]() (WO2021219089, INSCoV-601N (1)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 130 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512814![]() (WO2021219089, INSCoV-601F) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 130 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512885![]() (WO2021219089, INSCoV-601R (1A)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 140 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512870![]() (WO2021219089, INSCoV-601P (1A)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 140 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512872![]() (WO2021219089, INSCoV-601Q) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 150 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512761![]() (WO2021219089, INCoV-600C (2B)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 160 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512736![]() (WO2021219089, INCoV-600B (2A)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 170 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512580![]() (WO2021219089, INSCoV-517B) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 170 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512690![]() (WO2021219089, INSCoV-601T) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 170 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512703![]() (WO2021219089, INSCoV-614A (1B) | WO2021219089, INS...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 180 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512735![]() (WO2021219089, INCoV-600B (2)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 190 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512844![]() (WO2021219089, INSCoV-601K (2)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 190 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512757![]() (WO2021219089, INCoV-600C (2)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 200 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512833![]() (WO2021219089, INSCoV-601I (2)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 210 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512749![]() (WO2021219089, INCoV-600C) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 220 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512641![]() (WO2021219089, INSCoV-538A (1)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 230 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512565![]() (WO2021219089, INSCoV-517) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 240 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512478![]() (WO2021219089, INSCoV-501S) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 240 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512731![]() (WO2021219089, INCoV-600B (1)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 250 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512440![]() (WO2021219089, INSCoV-501G) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 260 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512751![]() (WO2021219089, INCoV-600C (1)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 270 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512627![]() (WO2021219089, INSCoV-537I) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 270 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512818![]() (WO2021219089, INSCoV-601G (2)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 270 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512638![]() (WO2021219089, INSCoV-538) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 280 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512423![]() (WO2021219089, INSCoV-501A) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 290 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512730![]() (WO2021219089, INCoV-600B) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 290 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512847![]() (WO2021219089, INSCoV-601L) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 300 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512734![]() (WO2021219089, INCoV-600B (1B)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 310 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512738![]() (WO2021219089, INCoV-600B (2B)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 310 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512756![]() (WO2021219089, INCoV-600C (1B)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 310 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512693![]() (WO2021219089, INSCoV-614) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 330 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512650![]() (WO2021219089, INSCoV-558) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 330 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512752![]() (WO2021219089, INCoV-600C (1A)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 340 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512733![]() (WO2021219089, INCoV-600B (1A)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 340 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512630![]() (WO2021219089, INSCoV-537K) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 360 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512869![]() (WO2021219089, INSCoV-601P) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 380 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512447![]() (WO2021219089, INSCoV-501I) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 390 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512655![]() (WO2021219089, INSCoV-558H) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 400 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512452![]() (WO2021219089, INSCoV-501L) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 400 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512728![]() (WO2021219089, INCoV-600A (3)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 410 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512617![]() (WO2021219089, INSCoV-537) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 420 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512726![]() (WO2021219089, INCoV-600A (2)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 430 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512779![]() (WO2021219089, INCoV-600K (2)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 430 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512890![]() (WO2021219089, INSCoV-601R (1B)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 440 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512455![]() (WO2021219089, INSCoV-501M) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 450 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512780![]() (WO2021219089, INSCoV-600L) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 450 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512758![]() (WO2021219089, INCoV-600C (2A)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 450 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512653![]() (WO2021219089, INSCoV-558A) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 470 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512468![]() (WO2021219089, INSCoV-501R) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 480 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512781![]() (WO2021219089, INSCoV-600M) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 500 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512763![]() (WO2021219089, INCoV-600D) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 520 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512838![]() (WO2021219089, INSCoV-601J (2)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 530 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512765![]() (WO2021219089, INCoV-600F) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 530 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512774![]() (WO2021219089, INCoV-600J (1) | WO2021219089, INCoV...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 530 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512719![]() (WO2021219089, INCoV-600A) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 540 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512463![]() (WO2021219089, INSCoV-501P) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 560 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512471![]() (WO2021219089, INSCoV-501R (1)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 570 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512764![]() (WO2021219089, INCoV-600E) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 570 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512428![]() (WO2021219089, INSCoV-501B) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512438![]() (WO2021219089, INSCoV-501E) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512607![]() (WO2021219089, INSCoV-536) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 620 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512445![]() (WO2021219089, INSCoV-501H (1)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 630 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512768![]() (WO2021219089, INCoV-600H) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 660 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512539![]() (WO2021219089, INSCoV-503E) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 660 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512418![]() (WO2021219089, INSCoV-501) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 680 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512444![]() (WO2021219089, INSCoV-501H) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 720 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512644![]() (WO2021219089, INSCoV-539) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 800 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512724![]() (WO2021219089, INCoV-600A (1)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 840 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512639![]() (WO2021219089, INSCoV-538A) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 900 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512540![]() (WO2021219089, INSCoV-503F) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 940 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512521![]() (WO2021219089, INSCoV-503) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 980 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512595![]() (WO2021219089, INSCoV-523) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 980 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512892![]() (WO2021219089, INSCoV-601S (1B)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 980 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512766![]() (WO2021219089, INCoV-600G) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 990 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512532![]() (WO2021219089, INSCoV-503B) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512603![]() (WO2021219089, INSCoV-535) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 1.04E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512785![]() (WO2021219089, INSCoV-600N) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 1.06E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512451![]() (WO2021219089, INSCoV-501K (2)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 1.07E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512658![]() (WO2021219089, INSCoV-559) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 1.08E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512792![]() (WO2021219089, INSCoV-600O) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 1.09E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512407![]() (WO2021219089, INSCoV-110A) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid PDB UniChem | WIPO WO2021219089 | n/a | n/a | 1.14E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512849![]() (WO2021219089, INSCoV-601M) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 1.15E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512813![]() (WO2021219089, INSCoV-601CA) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 1.15E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512770![]() (WO2021219089, INCoV-600I) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 1.18E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512559![]() (WO2021219089, INSCoV-516) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 1.18E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512708![]() (WO2021219089, INSCoV-574) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 1.27E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512602![]() (WO2021219089, INSCoV-534) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 1.28E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512534![]() (WO2021219089, INSCoV-503C) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 1.38E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512811![]() (WO2021219089, INSCoV-600X) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 1.39E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512686![]() (WO2021219089, INSCoV-537 (2)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 1.44E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512457![]() (WO2021219089, INSCoV-501O) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512701![]() (WO2021219089, INSCoV-614 (2B)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 1.70E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512572![]() (WO2021219089, INSCoV-517 (2)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 1.94E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512409![]() (WO2021219089, INSCoV-110A (1)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid PDB UniChem | WIPO WO2021219089 | n/a | n/a | 1.98E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512812![]() (WO2021219089, INSCoV-600Y) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 1.99E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512552![]() (WO2021219089, INSCoV-507) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 2.13E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512411![]() (WO2021219089, INSCoV-110A (2)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 2.15E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512798![]() (WO2021219089, INSCoV-600Q (2)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 2.22E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512544![]() (WO2021219089, INSCoV-503G) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 2.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512647![]() (WO2021219089, INSCoV-549) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 2.49E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512437![]() (WO2021219089, INSCoV-501D) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 2.51E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512522![]() (WO2021219089, INSCoV-503A) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 2.63E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512538![]() (WO2021219089, INSCoV-503D) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 2.65E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512809![]() (WO2021219089, INSCoV-600R (2A)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 2.93E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512868![]() (WO2021219089, INSCoV-601O) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 3.06E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512578![]() (WO2021219089, INSCoV-517A (1B)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 3.25E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512867![]() (WO2021219089, INSCoV-601N (2)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 3.49E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512663![]() (WO2021219089, INSCoV-560A) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 4.34E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512718![]() (WO2021219089, INSCoV-576) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 4.67E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512481![]() (WO2021219089, INSCoV-502) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 4.82E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512710![]() (WO2021219089, INSCoV-574A) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 4.97E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512703![]() (WO2021219089, INSCoV-614A (1B) | WO2021219089, INS...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 5.05E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512675![]() (WO2021219089, INSCoV-571) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 6.28E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512808![]() (WO2021219089, INSCoV-600R (2)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 6.45E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512704![]() (WO2021219089, INSCoV-614A (1A) | WO2021219089, INS...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 6.74E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512901![]() (WO2021219089, INSCoV-614 (2A)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 6.94E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512793![]() (WO2021219089, INSCoV-600Q) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 6.98E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512706![]() (WO2021219089, INSCoV-616) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 8.36E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512551![]() (WO2021219089, INSCoV-505) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 8.65E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512704![]() (WO2021219089, INSCoV-614A (1A) | WO2021219089, INS...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 9.11E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512642![]() (WO2021219089, INSCoV-538A (2)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 9.60E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512430![]() (WO2021219089, INSCoV-501C) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 9.82E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512582![]() (WO2021219089, INSCoV-517C (1)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 1.12E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512585![]() (WO2021219089, INSCoV-517C (2)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 1.14E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512909![]() (WO2021219089, INSCoV-615) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 1.14E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512597![]() (WO2021219089, INSCoV-531) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 1.27E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512799![]() (WO2021219089, INSCoV-600R) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 1.28E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512871![]() (WO2021219089, INSCoV-601P (1B)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 1.37E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512545![]() (WO2021219089, INSCoV-504) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 1.63E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512807![]() (WO2021219089, INSCoV-600R (1B)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 1.67E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512911![]() (WO2021219089, INSCoV-704) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 1.94E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512805![]() (WO2021219089, INSCoV-600R (1)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 1.99E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512797![]() (WO2021219089, INSCoV-600Q (1)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 2.26E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512897![]() (WO2021219089, INSCoV-612) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 2.32E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512910![]() (WO2021219089, INSCoV-618) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | >2.50E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512594![]() (WO2021219089, INSCoV-520) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | >2.50E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512810![]() (WO2021219089, INSCoV-600R (2B)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | >2.50E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512636![]() (WO2021219089, INSCoV-537L) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | >2.50E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM70763![]() (2-(N-(2-chloro-1-oxoethyl)-3,4-dimethylanilino)-N-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem Similars | WIPO WO2021219089 | n/a | n/a | >2.50E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512443![]() (WO2021219089, INSCoV-501G (1)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | >2.50E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512558![]() (WO2021219089, INSCoV-515) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | >2.50E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512646![]() (WO2021219089, INSCoV-539A) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | >2.50E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512649![]() (WO2021219089, INSCoV-557A) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | >2.50E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512899![]() (WO2021219089, INSCoV-614 (1A)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | >2.50E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512671![]() (WO2021219089, INSCoV-570) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | >2.50E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512806![]() (WO2021219089, INSCoV-600R (1A)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | >2.50E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512711![]() (WO2021219089, INSCoV-575) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | >2.50E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512589![]() (WO2021219089, INSCoV-517C (4)) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | >2.50E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512707![]() (WO2021219089, INSCoV-620) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | >2.50E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512553![]() (WO2021219089, INSCoV-508) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | >2.50E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512413![]() (WO2021219089, INSCoV-110-1) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | 3.60E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512417![]() (WO2021219089, INSCoV-110D) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | KEGG PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | >5.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512414![]() (WO2021219089, INSCoV-110-2) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | >5.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512412![]() (WO2021219089, INSCoV-110B) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | >5.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512565![]() (WO2021219089, INSCoV-517) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | n/a | n/a | 3.22E+3 | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description SARS-CoV-2 was provided by Korea Centers for Disease Control and Prevention (KCDC) . Vero cells were acquired from the ATCC and maintained in the Dul... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512573![]() (WO2021219089, INSCoV-517A) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | WIPO WO2021219089 | n/a | n/a | n/a | n/a | 1.11E+4 | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description SARS-CoV-2 was provided by Korea Centers for Disease Control and Prevention (KCDC) . Vero cells were acquired from the ATCC and maintained in the Dul... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM50180655![]() (A-157378-0 | A-157378.0 | ABT-378 | CHEBI:31781 | ...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | Purchase DrugBank MCE KEGG PC cid PC sid PDB UniChem Similars | WIPO WO2021219089 | n/a | n/a | n/a | n/a | 1.39E+4 | n/a | n/a | n/a | n/a |
Insilico Medicine Ip Limited WIPO | Assay Description SARS-CoV-2 was provided by Korea Centers for Disease Control and Prevention (KCDC) . Vero cells were acquired from the ATCC and maintained in the Dul... | WIPO WO2021219089 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM512815![]() (WO2021219089, INSCoV-601G) |